⚕ GalenOps CRO console
← 703 (USA)

703-1076

completed
Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. Phase II · Site: 703 (USA) (Dr. Okafor) · consented 2013-10-25
Adverse events
7
Serious AEs
0
Open data queries
0
Luna dropout signal
–

Adverse events

mild assessed 2026-08-18

Mild APPLICATION SITE DERMATITIS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-11-23 (study day 30.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild APPLICATION SITE PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-11-23 (study day 30.0); relationship: PROBABLE

moderate assessed 2026-08-18

Moderate APPLICATION SITE PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-11-23 (study day 30.0); relationship: PROBABLE

moderate assessed 2026-08-18

Moderate BENIGN PROSTATIC HYPERPLASIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-11-20 (study day 27.0); relationship: NONE

moderate assessed 2026-08-18

Moderate BIOPSY PROSTATE — outcome: RECOVERED/RESOLVED; onset 2013-11-16 (study day 23.0); relationship: NONE

moderate assessed 2026-08-18

Moderate HYPERCHOLESTEROLAEMIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2007; relationship: NONE

mild assessed 2026-08-18

Mild HYPERHIDROSIS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-11-25 (study day 32.0); relationship: POSSIBLE

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.